Literature DB >> 23487258

Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings.

Katherine L Wisner1, Dorothy K Y Sit, Mary C McShea, David M Rizzo, Rebecca A Zoretich, Carolyn L Hughes, Heather F Eng, James F Luther, Stephen R Wisniewski, Michelle L Costantino, Andrea L Confer, Eydie L Moses-Kolko, Christopher S Famy, Barbara H Hanusa.   

Abstract

IMPORTANCE: The period prevalence of depression among women is 21.9% during the first postpartum year; however, questions remain about the value of screening for depression.
OBJECTIVES: To screen for depression in postpartum women and evaluate positive screen findings to determine the timing of episode onset, rate and intensity of self-harm ideation, and primary and secondary DSM-IV disorders to inform treatment and policy decisions.
DESIGN: Sequential case series of women who recently gave birth.
SETTING: Urban academic women's hospital. PARTICIPANTS: During the maternity hospitalization, women were offered screening at 4 to 6 weeks post partum by telephone. Screen-positive women were invited to undergo psychiatric evaluations in their homes. MAIN OUTCOMES AND MEASURES: A positive screen finding was an Edinburgh Postnatal Depression Scale (EPDS) score of 10 or higher. Self-harm ideation was assessed on EPDS item 10: "The thought of harming myself has occurred to me" (yes, quite often; sometimes; hardly ever; never). Screen-positive women underwent evaluation with the Structured Clinical Interview for DSM-IV for Axis I primary and secondary diagnoses.
RESULTS: Ten thousand mothers underwent screening, with positive findings in 1396 (14.0%); of these, 826 (59.2%) completed the home visits and 147 (10.5%) completed a telephone diagnostic interview. Screen-positive women were more likely to be younger, African American, publicly insured, single, and less well educated. More episodes began post partum (40.1%), followed by during pregnancy (33.4%) and before pregnancy (26.5%). In this population, 19.3% had self-harm ideation. All mothers with the highest intensity of self-harm ideation were identified with the EPDS score of 10 or higher. The most common primary diagnoses were unipolar depressive disorders (68.5%), and almost two-thirds had comorbid anxiety disorders. A striking 22.6% had bipolar disorders. CONCLUSIONS AND RELEVANCE: The most common diagnosis in screen-positive women was major depressive disorder with comorbid generalized anxiety disorder. Strategies to differentiate women with bipolar from unipolar disorders are needed. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00282776.

Entities:  

Mesh:

Year:  2013        PMID: 23487258      PMCID: PMC4440326          DOI: 10.1001/jamapsychiatry.2013.87

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  56 in total

1.  Psychiatric disorders with postpartum onset: possible early manifestations of bipolar affective disorders.

Authors:  Trine Munk-Olsen; Thomas Munk Laursen; Samantha Meltzer-Brody; Preben Bo Mortensen; Ian Jones
Journal:  Arch Gen Psychiatry       Date:  2011-12-05

2.  Screening for bipolar disorder in a primary care practice.

Authors:  Amar K Das; Mark Olfson; Marc J Gameroff; Daniel J Pilowsky; Carlos Blanco; Adriana Feder; Raz Gross; Yuval Neria; Rafael Lantigua; Steven Shea; Myrna M Weissman
Journal:  JAMA       Date:  2005-02-23       Impact factor: 56.272

3.  SUICIDALITY in the perinatal period: comparison of two self-report instruments. Results from PND-ReScU.

Authors:  Mauro Mauri; Annalisa Oppo; Chiara Borri; Susanna Banti
Journal:  Arch Womens Ment Health       Date:  2012-01-04       Impact factor: 3.633

4.  Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom.

Authors:  Roch Cantwell; Thomas Clutton-Brock; Griselda Cooper; Andrew Dawson; James Drife; Debbie Garrod; Ann Harper; Diana Hulbert; Sebastian Lucas; John McClure; Harry Millward-Sadler; James Neilson; Catherine Nelson-Piercy; Jane Norman; Colm O'Herlihy; Margaret Oates; Judy Shakespeare; Michael de Swiet; Catherine Williamson; Valerie Beale; Marian Knight; Christopher Lennox; Alison Miller; Dharmishta Parmar; Jane Rogers; Anna Springett
Journal:  BJOG       Date:  2011-03       Impact factor: 6.531

Review 5.  Screening for postnatal depression in primary care: cost effectiveness analysis.

Authors:  Mike Paulden; Stephen Palmer; Catherine Hewitt; Simon Gilbody
Journal:  BMJ       Date:  2009-12-22

6.  Beyond screening: assessment of perinatal depression in a perinatal care setting.

Authors:  Laura Miller; Michele Shade; Vamsi Vasireddy
Journal:  Arch Womens Ment Health       Date:  2009-06-05       Impact factor: 3.633

7.  Psychiatric disorders in pregnant and postpartum women in the United States.

Authors:  Oriana Vesga-López; Carlos Blanco; Katherine Keyes; Mark Olfson; Bridget F Grant; Deborah S Hasin
Journal:  Arch Gen Psychiatry       Date:  2008-07

8.  The Edinburgh Postnatal Depression Scale detects but does not distinguish anxiety disorders from depression in mothers of infants.

Authors:  Heather J Rowe; Jane R W Fisher; Wai May Loh
Journal:  Arch Womens Ment Health       Date:  2008-05-08       Impact factor: 3.633

9.  The effects of postpartum depression on maternal-infant interaction: a meta-analysis.

Authors:  C T Beck
Journal:  Nurs Res       Date:  1995 Sep-Oct       Impact factor: 2.381

Review 10.  Perinatal disorders: advancing public health opportunities.

Authors:  Katherine L Wisner; Sarah Hudson Scholle; Bradley Stein
Journal:  J Clin Psychiatry       Date:  2008-10       Impact factor: 4.384

View more
  216 in total

1.  Mixed depression in the postpartum period: diagnostic and treatment issues.

Authors:  Verinder Sharma
Journal:  J Psychiatry Neurosci       Date:  2013-11       Impact factor: 6.186

2.  Exposure to selective serotonin reuptake inhibitors in late pregnancy increases the risk of persistent pulmonary hypertension of the newborn, but the absolute risk is low.

Authors:  Nancy Byatt; Marlene P Freeman
Journal:  Evid Based Nurs       Date:  2014-05-23

3.  Response to Sharma and Sommerdyk.

Authors:  Crystal T Clark; Katherine L Wisner
Journal:  Am J Psychiatry       Date:  2014-03       Impact factor: 18.112

4.  Four maternal characteristics determine the 12-month course of chronic severe postpartum depressive symptoms.

Authors:  Sheehan D Fisher; Dorothy K Sit; Amy Yang; Jody D Ciolino; Jackie K Gollan; Katherine L Wisner
Journal:  Depress Anxiety       Date:  2019-01-15       Impact factor: 6.505

Review 5.  Pharmacotherapy of postpartum depression: an update.

Authors:  Deborah R Kim; C Neill Epperson; Amy R Weiss; Katherine L Wisner
Journal:  Expert Opin Pharmacother       Date:  2014-04-29       Impact factor: 3.889

Review 6.  Psychiatric consultation to the postpartum mother.

Authors:  Eleanor A Anderson; Deborah R Kim
Journal:  Curr Psychiatry Rep       Date:  2015-04       Impact factor: 5.285

7.  Perinatal mental health: a review of progress and challenges.

Authors:  Louise M Howard; Hind Khalifeh
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

8.  Examining the relationship between perinatal depression and neurodevelopment in infants and children through structural and functional neuroimaging research.

Authors:  Christy Duan; Megan M Hare; Morganne Staring; Kristina M Deligiannidis
Journal:  Int Rev Psychiatry       Date:  2019-01-31

9.  Healthcare professionals' perspectives on identifying and managing perinatal anxiety: a qualitative study.

Authors:  Victoria Silverwood; Annabel Nash; Carolyn A Chew-Graham; Jacqualyn Walsh-House; Athula Sumathipala; Bernadette Bartlam; Tom Kingstone
Journal:  Br J Gen Pract       Date:  2019-10-31       Impact factor: 5.386

10.  Interaction of oxytocin level and past depression may predict postpartum depressive symptom severity.

Authors:  Suena H Massey; Stephanie A Schuette; Hossein Pournajafi-Nazarloo; Katherine L Wisner; C Sue Carter
Journal:  Arch Womens Ment Health       Date:  2016-03-08       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.